Clinical Trials in Cumberland, United States
Locations / Cumberland, United States
Delta Trials records 23 clinical trials conducted in Cumberland, United States, making it a notable site of clinical research activity. These trials across 255 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Cumberland has changed over time.
23
Total Trials
255
Conditions
0
Terminated since 2020
Browse by condition (255 total)
- Malignant solid neoplasm 3 trialsAll Malignant solid neoplasm trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- Stage iiia lung cancer ajcc v8 3 trialsAll Stage iiia lung cancer ajcc v8 trials
- Recurrent malignant solid neoplasm 3 trialsAll Recurrent malignant solid neoplasm trials
- Recurrent ovarian carcinoma 3 trialsAll Recurrent ovarian carcinoma trials
- Stage iiib lung cancer ajcc v8 3 trialsAll Stage iiib lung cancer ajcc v8 trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- Small lymphocytic lymphoma 2 trialsAll Small lymphocytic lymphoma trials
- All Recurrent malignant female reproductive system neoplasm trials
- Exocrine pancreas carcinoma 2 trialsAll Exocrine pancreas carcinoma trials
- All Locally advanced malignant solid neoplasm trials
- Recurrent fallopian tube carcinoma 2 trialsAll Recurrent fallopian tube carcinoma trials
- Advanced malignant solid neoplasm 2 trialsAll Advanced malignant solid neoplasm trials
- Stage ii lung cancer ajcc v8 2 trialsAll Stage ii lung cancer ajcc v8 trials
- Lung non-small cell carcinoma 2 trialsAll Lung non-small cell carcinoma trials
- All Anatomic stage iii breast cancer ajcc v8 trials
- Thyroid gland carcinoma 2 trialsAll Thyroid gland carcinoma trials
- All Lung non-squamous non-small cell carcinoma trials
- Recurrent endometrial carcinoma 2 trialsAll Recurrent endometrial carcinoma trials